Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization

Annales de Chirurgie Plastique Esthetique

Volumn 59, Issue 2, 2014, Pages

  Sorin, T ^a,c   Fyad, J P ^a   Pujo, J ^a,c   Colson, T ^c   Bordes, V ^b   Leroux, A ^a   Marchal, F ^a   Brix, M ^a,c   Simon, E ^c   Verhaeghe, J L ^a   Classe, J M ^b   Dolivet, G ^a  

^a Service d'anatomie pathologique Institut de cancérologie de Lorraine   (France)

^b UMR INSERM U892 CNRS 6299   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Breast neoplasm; Breast reconstruction; Incidence study; Mammaplasty; Mammography; Occult breast cancer; Reconstructive surgical procedures

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; BREAST NEOPLASMS; BREAST RECONSTRUCTION; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CLINICAL TRIAL; FEMALE; FOLLOW UP; FRANCE; HUMAN; INCIDENCE; INCIDENTAL FINDING; MASTECTOMY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; REOPERATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR INVASION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; INCIDENTAL FINDINGS; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; RADIOTHERAPY, ADJUVANT; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84897574146     PISSN: 02941260     EISSN: 1768319X     Source Type: Journal    
DOI: 10.1016/j.anplas.2013.12.007     Document Type: Article

References (21)

1. Arveux P., Colonna M., Molinié F., Trétarre B. Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 2013, Institut de veille sanitaire, France.
2. Kheirelseid E.A., Jumustafa H., Miller N., Curran C., Sweeney K., Malone C., et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Res Treat 2011, 126:131-140.
3. Beinart G., Gonzalez-Angulo A.M., Broglio K., Mejia J., Ruggeri A., Mininberg E., et al. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. Clin Breast Cancer 2007, 7:867-874.
4. Robinson E., Rennert G., Rennert H.S., Neugut A.L. Survival of first and second primary breast cancer. Cancer 1993, 71:172-176.
5. Snyderman R.K., Lizardo J.G. Statistical study of malignancies found before, during, or after routine breast plastic operations. Plast Reconstr Surg 1960, 25:253-256.
6. Pitanguy I., Torres E.T. Histological aspects of mammary gland tissue in cases of plastic surgery. Br J Plast Surg 1964, 17:297-302.
7. Pitanguy I., Torres E., Salgado F., Pires Viana G.A. Breast pathology and reduction mammaplasty. Plast Reconstr Surg 2005, 115:729-734.
8. Boice J.D., Persson I., Brinton L.A., Hober M., McLaughlin J.K., Bolt W.J., et al. Breast cancer following breast reduction surgery in Sweden. Plast Reconstr Surg 2000, 106:755-762.
9. Jensen D.A., Murphy M., Kind G.M., Sands K. Breast cancer in reduction mammaplasty: case reports and a survey of plastic surgerons. Plast Reconstr Surg 1998, 101:361-364.
10. Titley O.G., Armstrong A.P., Christie J.L., Fatah M.F. Pathological findings in breast reduction surgery. Br J Plast Surg 1996, 49:447-451.
11. Tang C.L., Brown M.H., Levine R., Sloan M., Chong N., Holowaty E. Breast cancer found at the time of breast reduction. Plast Reconstr Surg 1999, 103:1682-1686.
12. Colleau M., Magalon G., Bonnier P. Cancer du sein diagnostiqué par la réduction mammaire. Étude rétrospective sur une période de trois ans. Ann Chir Plast Esteth 2005, 50:127-133.
13. Dotto J., Kluk M., Geramizadeh B., Tavassoli Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases. Int J Surg Patho 2008, 16:25-30.
14. Colwell A.S., Kukreja J., Breuing K.H., Lester S., Orgill D.P. Occult breast carcinoma in reduction mammapasty specimens: 14 year experience. Plast Rescontr Surg 2004, 113:1984-1988.
15. Slezak S., Bluebond-Langner R. Occult carcinoma in 866 reduction mammaplasties: preserving the choice of lumpectomy. Plast Reconst Surg 2011, 127:525-530.
16. Hassan F.E., Pacifico M.D. Should we be analysing breast reduction specimens? A systematic analysis of over 1000 consecutive cases. Aesth Plast Surg 2012, 36:1105-1113.
17. Rietjens M., Petit J.Y., Contesso G., Bertin F., Gilles R. The role of reduction mammaplasty in oncology. Eur J Plast Surg 1997, 20:246-250.
18. Goyal A., Coulson S.G., Wu J.M., Suvarna S.K., Reed M.W.R., Caddy C.M. Occult breast carcinoma in breast reduction specimens in european women. Brest Cancer Res Treat 2011, 128:749-755.
19. Boice J.D., Friis S., McLaughlin J.K., Mellemkjaer L., Blot W.J., Fraumeni J.F., Olsen J.H. Cancer following breast reduction surgery in Denmark. Cancer Causes Contr 1997, 8:253-258.
20. Tarone R.E., Lipworth L., Young L., McLaughlin J.K. Breast reduction surgery and breast cancer risk: does reduction mammaplasty have a role in primary prevention strategies for women at hight risk of breast cancer?. Plast Reconctr Surg 2004, 133:2104-2110.
21. Palmieri B., Costa A., Benuzzi G. Breast reduction and cancer in the gland remanant: a review. Breast Cancer Res Treat 2005, 91:283-290.